| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Steven L. Chapman
Also a director
Chief Executive Officer, President and Director
|
46 | Not stated | Not stated | $14,957,319 | |
|
Michael B. Brophy
Chief Financial Officer
|
45 |
Since 2017
9 years
|
Not stated | $5,460,022 | |
|
John Fesko
PRESIDENT, CHIEF BUS. OFFICER
Title from the Form 4 dated Aug 6, 2026
|
46 | Not stated | 2014 | $5,052,790 | |
|
Matthew Rabinowitz
Also a director
Executive Chairman
|
52 | Not stated | Not stated | $11,283,382 | |
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER
Title from the Form 4 dated Aug 3, 2026
|
56 | Not stated | 2004 | Not reported | |
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS
Title from the Form 4 dated Oct 1, 2026
|
43 | Not stated | 2011 | $5,367,000 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
The proxy filed Apr 23, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...
